SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Lytix Biopharma Announces Regulatory Approval by Norwegian and Swedish Authorities to Commence Phase I Clinical Trial of Oncopore(TM) (LTX-315) in Cancer